Voyager Therapeutics Appoints Grace E. Colón, Ph.D., to its Board of Directors

December 14, 2022

https://www.globenewswire.com/news-release/2022/12/14/2573503/36461/en/Voyager-Therapeutics-Appoints-Grace-E-Col%C3%B3n-Ph-D-to-its-Board-of-Directors.html

CAMBRIDGE, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq:VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced the appointment of Grace E. Colón, Ph.D., to its Board of Directors. Dr. Colón has more than 25 years of experience as a healthcare leader, investor and entrepreneur; she most recently served as President, CEO and Director of clinical-stage biotechnology company InCarda Therapeutics, Inc.

Read more at globenewswire.com

Related news for (VYGR)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.